Back to Clinical Trials Overview

Back To Cancer Clinical Trials

Your search for "Hodgkin's Lymphoma" returned 6 results:

“Protocol 2603: Multi-center, open-label randomized study of single or double myeloablative cord blood transplantation with or without infusion of off-the-shelf ex vivo expanded cryospreserved cord blood progenitor cells in patients with hematologic malignancies”
Principal Investigator(s): Dr. Alla Keyzner

A multicenter safety study of unlicensed, investigational cryopreserved cord blood units (CBUs) manufactured by the National Cord Blood Program (NCBP) and provided for unrelated hematopoietic stem cell transplantation of pediatric and adult patients
Principal Investigator(s): Luis M. Isola

A Randomized, Open-label, Phase 3 Trial of A+AVD Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma
Principal Investigator(s): Amir Steinberg

A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indications
Principal Investigator(s): Luis M. Isola

Phase II Study of the Addition of Azacitidine (IND #87574, NSC #102816) to Reduced-Intensity Conditioning Allogeneic Transplantation for Myelodysplasia (MDS) and Older Patients with AML
Principal Investigator(s): Luis M. Isola

BMT CTN 1101: A multi-center, phase 3, randomized trial of reduced intensity conditioning and transplantation of double unrelated umbilical cord blood versus HLA-Haploidentical related bone marrow for patients with hematological malignancies
Principal Investigator(s): Adriana Malone